All Mutect mutations 4. All SNV mutations called by Mutect and annotated by Oncotator for samples LTS-008_T, LTS-009_T, LTS-010_T, LTS-011_T, LTS-012_T, LTS-013_T, LTS-014_T, LTS-015_T, LTS-016_T. (TXT 13456 kb
Table S8. Summary of SNV mutations in N-T-M trio samples. (A) AluScan, (B) WES-Non-Lung, (C) WES-NSC...
Figure S1. Result of sanger sequencing. (A) Eleven mutations which were sanger sequenced. (B) - (H) ...
Overall survival according to the genomic imbalances. A. Telomeric allelic imbalance (TAI); B. Loss ...
All Mutect mutations 5. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 6. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 2. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 3. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 8. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 1. SNV mutations called by Mutect and annotated by Oncotator for samples LTS-00...
All Mutect mutations 7. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All CNV segs annotated. All CNV segs generated by Sequenza and annotated by Oncotator. (TXT 15904 kb
All Strelka indels. All Indels called by Strelka and annotated by Oncotator. (TXT 3458 kb
Clinicopathological data for MOTs. Table S2. Summary of whole exome sequencing statistics. Table S3....
CNV segment size as distribution per sample. Distribution of CNV segment size as percentage of chrom...
Table S9. The exact residue-by-residue SNV mutations in each sample of the AluScan N-T-M trio sample...
Table S8. Summary of SNV mutations in N-T-M trio samples. (A) AluScan, (B) WES-Non-Lung, (C) WES-NSC...
Figure S1. Result of sanger sequencing. (A) Eleven mutations which were sanger sequenced. (B) - (H) ...
Overall survival according to the genomic imbalances. A. Telomeric allelic imbalance (TAI); B. Loss ...
All Mutect mutations 5. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 6. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 2. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 3. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 8. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All Mutect mutations 1. SNV mutations called by Mutect and annotated by Oncotator for samples LTS-00...
All Mutect mutations 7. All SNV mutations called by Mutect and annotated by Oncotator for samples LT...
All CNV segs annotated. All CNV segs generated by Sequenza and annotated by Oncotator. (TXT 15904 kb
All Strelka indels. All Indels called by Strelka and annotated by Oncotator. (TXT 3458 kb
Clinicopathological data for MOTs. Table S2. Summary of whole exome sequencing statistics. Table S3....
CNV segment size as distribution per sample. Distribution of CNV segment size as percentage of chrom...
Table S9. The exact residue-by-residue SNV mutations in each sample of the AluScan N-T-M trio sample...
Table S8. Summary of SNV mutations in N-T-M trio samples. (A) AluScan, (B) WES-Non-Lung, (C) WES-NSC...
Figure S1. Result of sanger sequencing. (A) Eleven mutations which were sanger sequenced. (B) - (H) ...
Overall survival according to the genomic imbalances. A. Telomeric allelic imbalance (TAI); B. Loss ...